Efficacy and Safety Study With MYL-1401H and Neulasta

Clinical trial NCT02467868 · COMPLETED

Trial details

NCT number: NCT02467868
Sponsor: Mylan Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Neoplasms Chemotherapy-Induced Febrile Neutropenia

Start date: 2015-03-01
Primary completion: 2015-09-01
Enrollment: 193

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.